LambdaVision Inc.

Artificial retinal prostheses are poised to make a dramatic impact by restoring at least partial vision to people blinded by degenerative ophthalmic diseases. A number of companies are developing complex implantable microelectronic innovations, many with external hardware components, to stimulate the retina and overcome the photoreceptor cell deterioration that is the hallmark of these diseases. LambdaVision Inc. is taking a unique approach to restoring vision by developing a flexible, protein-based retinal implant designed to provide higher resolution and to be less surgically invasive than competing technologies.